Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Observational , Multicenter Study of Effectiveness of Efanesoctocog Alfa on Long-term Joint Health in Patients With Hemophilia A

NCT05911763 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT05911763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05911763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Observational , Multicenter Study of Effectiveness of Efanesoctocog Alfa on Long-term Joint Health in Patients With Hemophilia A
Lead sponsor
Sanofi
Phase
Observational
Overall status
Active, not recruiting
Start date
June 30, 2023
Completion date
September 17, 2030
Enrollment
200 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a